tiprankstipranks
Trending News
More News >
Shanghai Henlius Biotech, Inc. Class H (HK:2696)
:2696
Hong Kong Market

Shanghai Henlius Biotech, Inc. Class H (2696) Revenue

Compare
5 Followers

Shanghai Henlius Biotech, Inc. Class H Revenue

Shanghai Henlius Biotech, Inc. Class H had a revenue of 1.41B in the quarter ending Jun 30, 2025, with 0.00%. This bring the company's revenue in the last twelve months to 5.80B, Decreased 0.64%. In the fiscal year ending Dec 31, 2024, Shanghai Henlius Biotech, Inc. Class H had annual revenue of 5.72B with 6.11% growth.
Revenue (ttm)
5.80B
Revenue Growth
2.57%
P/S Ratio
5.94
Revenue/Employee
HK$1,628,577
Employees
3,515
Market Cap
HK$34.00B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
5.72B329.54M+106.11%
Dec 31, 2023
5.39B2.18B+167.82%
Dec 31, 2022
3.21B1.53B+191.07%
Dec 31, 2021
1.68B1.09B+286.34%
Dec 31, 2020
587.59M496.66M+646.20%
Dec 31, 2019
90.93M83.51M+1,225.29%
Dec 31, 2018
7.42M-26.49M+21.88%
Dec 31, 2017
33.91M